When Your Brain Runs Out of Gas: The Mitochondrial Crisis Behind Mental Illness

How I Started Seeing the Connection

Something kept showing up in my practice that didn’t fit the textbook explanations.

Patients came in with chronic pain, and I’d address the physical symptoms. But they’d also mention brain fog. Crushing fatigue. Anxiety that made even small decisions feel overwhelming.

At first, I thought these were separate issues. Pain is physical. Depression is mental. That’s how medical training teaches us to think.

Then I started looking at mitochondria.

What I found reshaped how I understand mental health.

What Happens When Your Brain’s Energy Budget Runs Dry

The Numbers Tell a Striking Story

Your brain makes up 2% of your body weight but consumes 20% of your energy.1

That’s a metabolic demand 10 times higher per gram than any other tissue. Here’s what makes this even more precarious: the total ATP content in your entire brain at any moment is only about 2 grams.2

Your brain operates on an extremely tight energy budget with minimal reserves.

When Energy Production Fails

Under normal conditions, about 90% of brain ATP production happens in mitochondria through oxidative phosphorylation.3 When this system fails, neurons lose the ability to maintain essential functions.

Picture a battery running low. The cell loses its ability to pump calcium and sodium efficiently. Waste products accumulate. The membrane potential needed for neurotransmitter release drops.

But energy production isn’t the only problem.

These struggling mitochondria start producing excessive reactive oxygen species (ROS). ROS damages the cell membrane and triggers inflammatory cascades. The neuron becomes both energy-starved and inflamed at the same time.

The neuron is trying to regulate mood, process emotions, and manage stress responses while running on fumes.

Bottom line: When mitochondria fail, neurons lose both energy production and cellular integrity, creating the biological foundation for mood and cognitive symptoms.

Why Mental Illness Looks Like Mitochondrial Disease

The Research Shows Specific Patterns

Multiple studies have found specific patterns of mitochondrial complex I pathology that vary between schizophrenia, bipolar disorder, and major depression.

Schizophrenia shows reductions in the prefrontal cortex and striatum. Depression shows consistent reductions in the cerebellum.4

The evidence includes:

• Decreased mitochondrial respiration

• Changes in mitochondrial morphology

• Increases in mitochondrial DNA polymorphisms and mutations

• Downregulation of nuclear mRNA molecules and proteins involved in mitochondrial respiration

• Decreased high-energy phosphates with decreased pH in the brain5

Patients with bipolar disorder show a 2.12-fold increase in mitochondrial DNA deletion in the dorsolateral prefrontal cortex compared to controls.6

That means accumulated mitochondrial damage in brain regions governing executive function and emotional regulation.

This is measurable cellular dysfunction, not a metaphor.

Bottom line: Mental health disorders show distinct patterns of mitochondrial damage in specific brain regions, supporting a metabolic basis for psychiatric symptoms.

How Your Brain Decides What to Shut Down First

The Energy Hierarchy in Action

When mitochondrial energy production is limited, the brain operates an energy hierarchy that prioritizes essential functions like affective responses while downregulating more energy-demanding complex cognitive processes.7

This explains why mental fatigue and cognitive dysfunction occur alongside emotional dysregulation.

Working memory tasks are highly ATP-demanding, making them particularly sensitive to mitochondrial constraints. Executive function collapses when cellular energy fails.

This is about metabolic capacity, not willpower.

What This Looks Like in Real Life

I see this pattern constantly in my practice. People with chronic mental health conditions like anxiety or depression have a narrower window of tolerance, lower emotional endurance, and reduced threshold for fatigue. This mirrors in both directions between mental and physical realms.

Mental and physical exhaustion feed off each other.

Physical exhaustion leads to mental, emotional, and cognitive fatigue. Mental and emotional strain leads to physical depletion. The physical impact creates earlier exhaustion, fatigue, and impaired function, which reduces physical endurance and activity tolerance.

This indirectly narrows the window of tolerance on the mental health side and heightens symptoms of anxiety or depression.

Bottom line: Energy deficits force the brain to prioritize survival functions over complex cognition, explaining why executive function and emotional regulation fail together.

Why Inflammation Makes Everything Worse

The Chemical Environment That Changes Neural Communication

Neuroinflammation doesn’t look like visible swelling. It’s a chemical environment that changes how neurons communicate.

When mitochondria are dysfunctional and producing excess ROS, they trigger the release of pro-inflammatory cytokines. These cytokines interfere with neurotransmitter metabolism, particularly serotonin and dopamine.8

Here’s the critical part:

This inflammation affects the areas of the brain responsible for threat detection and emotional regulation. The amygdala becomes hyperactive while the prefrontal cortex struggles to maintain executive control.

The result is heightened threat perception, impaired emotional regulation, and reduced capacity to problem-solve or find motivation.

That’s why anxiety and depression emerge from this specific pattern. The person isn’t just tired. Their brain is interpreting the world as more dangerous and less manageable because the cells governing those functions are compromised.

This isn’t a character flaw or purely psychological issue. It’s a metabolic crisis affecting the exact neural circuits that regulate mood and stress response.

New Research on Immune-Brain Connections

Recent research from 2025 shows that inflammatory cytokines like IL-17A increase the excitability of neurons in the basolateral amygdala, while anti-inflammatory cytokine IL-10 has opposite effects.9

The immune system bidirectionally modulates anxiety by directly engaging receptors in emotion-regulating brain circuits.

Bottom line: Mitochondrial dysfunction creates inflammation that directly alters threat perception and emotional regulation, producing the specific symptoms of anxiety and depression.

Why Antidepressants Often Fall Short

The Limits of Targeting Neurotransmitters Alone

Brain tissue is highly metabolically active, depending on oxidative phosphorylation for its energy source. It has lower rates of regeneration and inadequate antioxidant potential compared to other cells.10

This makes the central nervous system uniquely vulnerable to oxidative damage.

The Numbers on Treatment Response

Only 30-50% of patients achieve remission with conventional antidepressant therapies. Observable therapeutic benefits usually take 6-8 weeks to emerge.11

This delay might reflect the time required to restore mitochondrial function rather than simply modulating neurotransmitters.

Studies show that the reduction of depressive symptoms is accompanied by decreases in inflammatory factors. Multiple antidepressants significantly downregulate peripheral biomarkers like IL-1β, IL-6, and TNF-α.12

Their effectiveness might depend partly on anti-inflammatory effects rather than purely neurochemical ones.

When treatment focuses only on neurotransmitters, it addresses one part of the problem. But if the underlying issue is that neurons don’t produce enough energy to function properly, and they’re sitting in an inflammatory environment, medication alone won’t restore full function.

Bottom line: Conventional antidepressants work for some people but fail for many because they don’t address the underlying metabolic and inflammatory dysfunction.

From Cells to Lived Experience

How Energy Deficits Create Physical Symptoms

The brain spends just under half of its energy on non-signaling “housekeeping” processes essential for maintaining cellular integrity. This includes protein and lipid synthesis and mitochondrial proton leak.13

When energy is diverted to manage chronic stress or pain, these maintenance functions suffer, creating a cascade of cellular dysfunction.

ATP supplies the energy required for ions to traverse cell membranes, maintaining proper ionic balance inside and outside cells. Without sufficient energy, excessive ions accumulate inside neurons, causing swelling and cellular damage.14

This mechanism links energy deficits to both neurological and pain conditions.

How I Started Making This Connection

I started understanding this through muscle function. I first became interested in using urolithin A with geriatric patients to combat sarcopenia. But the potential for benefit extends to additional populations with musculoskeletal injuries or dysfunction as an adjunct in rehabilitation and recovery.

Exercise helps rehabilitation and recovery. But barriers like incomplete surrender to movement, apprehension about pain, decreased tolerance to discomfort, uncertain guidelines for safe versus unsafe movements, and deconditioning all contribute to impaired muscle recovery and function.

When people remain sedentary because of pain, weakness, or apprehension, this perpetuates deconditioning on a cellular level.

Bottom line: Energy deficits affect cellular maintenance functions, creating a direct link between metabolic dysfunction and both mental health and chronic pain.

Breaking the Deconditioning Cycle

When Body and Mind Are Both Telling You to Stop

People with chronic mental health conditions like anxiety or depression often have a narrower window of tolerance, lower emotional endurance, and reduced threshold for fatigue. This pattern mirrors in both directions between mental and physical realms.

When you optimally apply mechanotransduction through connective tissues using healthy motor patterns and appropriate stress on tissues, you promote healthy organization of collagen and integrity through proliferation, remodeling, and regenerative processes.

This helps maintain and increase mitochondrial function and uses less energy to accomplish the same tasks. Energy expenditure is preserved and fatigue states are delayed.

Movement isn’t just about burning calories or building strength. It’s reorganizing tissue at the cellular level in a way that makes mitochondria more efficient.

The Challenge of Overcoming Fear

When someone has been stuck in that protective pattern for months or years, their mitochondria are deconditioned AND their nervous system is hypersensitive to threat.

How do you help someone break that cycle when both body and brain are signaling danger?

Through graded exposure to neutral or positive sensations and helping them tolerate small doses of discomfort with reappraisal of safety. This is the premise of somatic tracking with Pain Reprocessing Therapy.

As people become more active and less deconditioned, there’s better activity and exertional tolerance, more efficient mitochondrial function, and less energy expenditure during movements. This delays the onset of fatigue and overwhelm states.

Bottom line: Movement and nervous system regulation work together to recondition mitochondria and expand tolerance for activity, breaking the fear-avoidance cycle.

Evidence-Based Approaches to Support Mitochondrial Function

Nutrition and Supplementation

Urolithin A or foods like pomegranates that contain components of these compounds are beneficial. Modified exercise that is safer and more tolerable also helps.

Movement Strategies That Work

This includes:

• Isometric exercises – muscle contraction without joint movement

• Closed-chain kinetics – exercises where the distal segment is fixed

• Aquatherapy – water-based movement reducing joint stress

• Graded motor imagery – mental rehearsal before physical movement

The goal is to use movement and somatic therapies to ascend the autonomic hierarchy to a ventral vagal state. Focus on surrendering to safe movements to remove self-imposed barriers created by anticipation of pain and fear.

Understanding Reactive Oxygen Species Differently

Reactive oxygen species have been identified as important plasticity signals in the nervous system, monitoring neuronal activity and regulating structural changes.15

What we’ve considered purely “destructive” stress molecules actually serve adaptive signaling functions when properly regulated.

Mitochondrial dysfunction and oxidative stress lead to maladaptive oxidative modifications of cellular macromolecules. This is associated with impaired synaptic neuroplasticity and the development of functional abnormalities in the brain.16

This provides a mechanistic link between cellular energy failure and altered emotional processing.

Bottom line: Targeted nutrition, modified movement, and nervous system regulation offer practical approaches to support mitochondrial function and reduce symptoms.

What Needs to Change in How We Treat Mental Health

Moving Beyond Symptom Management

This kind of humanistic and holistic thinking is vital to achieving outcomes that move the needle for patients. We need more than short-sighted fixes to isolated problems.

We need to restore physical and mental fitness. We need to heal, not just manage symptoms.

The Clinical Application Gap

When you look at the future of psychiatry and pain treatment, the need for change becomes clear.

We need to stop treating the brain as separate from the body. Mental health symptoms often have metabolic underpinnings. Mitochondrial function, inflammation, nervous system regulation, and movement need to be addressed as integrated components of mental health care.

The data is clear. The mechanisms are understood. Clinical application is what’s missing.

Most psychiatrists still treat depression with an SSRI and send the patient to physical therapy for pain, keeping them separate. But they’re both downstream from the same source.

What This Looks Like in Practice

When mitochondria don’t produce enough ATP, the neuron loses its ability to maintain the ion gradients it needs to fire properly. The cell loses its ability to pump calcium and sodium efficiently, clear out waste products, and maintain the membrane potential needed for neurotransmitter release.

The neuron becomes both energy-starved and inflamed. It’s trying to regulate mood, process emotions, and manage stress responses while running on fumes.

That’s when executive function problems emerge. Emotional dysregulation appears. The ability to tolerate stress that would normally be manageable disappears.

This is what I see in clinical practice every day.

When we address it at the mitochondrial level, when we support cellular energy production, reduce inflammation, and help the nervous system downregulate, people get better.

Not just symptom management. Actual healing.

Bottom line: The future of mental health care requires integrating metabolic support, inflammation reduction, and nervous system regulation into standard treatment protocols.

Key Takeaways

---

• Mental health disorders are metabolic crises at the cellular level, not purely neurochemical imbalances. When mitochondria fail, neurons become both energy-starved and inflamed.

• The brain uses 20% of your energy despite being only 2% of body weight, making it extremely vulnerable to energy deficits. Limited ATP reserves mean even small disruptions in energy production have immediate effects.

• Specific patterns of mitochondrial dysfunction appear in different psychiatric disorders. Schizophrenia, bipolar disorder, and depression each show distinct mitochondrial damage in brain regions governing their characteristic symptoms.

• Mental and physical exhaustion share the same biological mechanism. Mitochondrial dysfunction creates a bidirectional relationship where physical deconditioning worsens mental health symptoms and vice versa.

• Conventional antidepressants address only part of the problem because they target neurotransmitters but not cellular energy production or inflammation. This explains why only 30-50% of patients achieve remission.

• Movement and nervous system regulation are therapeutic interventions, not just lifestyle recommendations. Modified exercise, somatic therapies, and graded exposure to safe movements support mitochondrial reconditioning.

• The future of mental health care requires integration. Mitochondrial support, inflammation reduction, and nervous system regulation need to become standard components of treatment protocols alongside conventional approaches.

---

About the Author

Dr. Zev Nevo is a double board-certified physiatrist, chronic pain survivor, and founder of the Body & Mind Pain Center. He helps people with persistent pain rebuild capacity and confidence using an evidence-based, trauma-informed mind-body rehabilitation approach.

Listen: Mind Your Body Podcast

Learn & Join: Mind-Body Rehabilitation Community

Visit the Clinic: Body & Mind Pain Center

Medical Disclaimer

The information in this article is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article. New or changing pain symptoms should always be properly evaluated by a medical professional.

References

1 Raichle ME, Gusnard DA. Appraising the brain’s energy budget. Proc Natl Acad Sci U S A. 2002;99(16):10237-10239. https://pmc.ncbi.nlm.nih.gov/articles/PMC5996770/

2 Erecińska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab. 1989;9(1):2-19. https://pmc.ncbi.nlm.nih.gov/articles/PMC5996770/

3 Kann O, Kovács R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol. 2007;292(2):C641-C657. https://www.pnas.org/doi/10.1073/pnas.0710766105

4 Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. PLoS One. 2010;5(2):e3676. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003676

5 Gardner A, Boles RG. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):730-743. https://pmc.ncbi.nlm.nih.gov/articles/PMC3010320/

6 Kato T. The other, forgotten genome: mitochondrial DNA and mental disorders. Mol Psychiatry. 2001;6(6):625-633. https://pmc.ncbi.nlm.nih.gov/articles/PMC3098560/

7 Shenhav A, Musslick S, Lieder F, et al. Toward a rational and mechanistic account of mental effort. Annu Rev Neurosci. 2017;40:99-124. https://pmc.ncbi.nlm.nih.gov/articles/PMC12236849/

8 Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22-34. https://pmc.ncbi.nlm.nih.gov/articles/PMC9570160/

9 Deng H, Gerfen CR, Huang ZJ. Cytokine signaling in neural circuits regulates social behavior. Cell. 2025;188(7):1617-1632. https://www.cell.com/cell/fulltext/S0092-8674(25)00278-8

10 Hroudová J, Fišar Z. Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry Clin Neurosci. 2011;65(2):130-141. https://academic.oup.com/braincomms/article/6/1/fcad356/7504872

11 Strawbridge R, Young AH, Cleare AJ. Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat. 2017;13:1245-1262. https://www.sciencedirect.com/science/article/abs/pii/S0889159120323837

12 Köhler CA, Freitas TH, Maes M, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5):373-387. https://www.nature.com/articles/s41398-022-02297-y

13 Harris JJ, Jolivet R, Attwell D. Synaptic energy use and supply. Neuron. 2012;75(5):762-777. https://pmc.ncbi.nlm.nih.gov/articles/PMC4560575/

14 Swaminathan N. Why does the brain need so much power? Scientific American. 2008. https://www.scientificamerican.com/article/why-does-the-brain-need-s/

15 University of Cambridge. Regulation of dendritic and synaptic plasticity by metabolic reactive oxygen species. 2025. https://www.zoo.cam.ac.uk/2025-26-projects/regulation-dendritic-and-synaptic-plasticity-metabolic-reactive-oxygen-species

16 Andreazza AC, Young LT. The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int J Neuropsychopharmacol. 2014;17(7):1039-1052. https://link.springer.com/10.1007/978-3-642-30018-9_83